Liva is a leading digital therapeutics company that advances digital-first delivery of behaviour change programmes to improve health outcomes globally, at scale. Our team of dedicated healthcare professionals create personalised change programmes to support people in their journey to prevent, manage and treat obesity, type-2 diabetes and prediabetes and other cardiometabolic conditions. The safety and efficacy of our digital therapeutic programmes are well-supported by extensive evidence from randomised controlled trials (RCTs) and other clinical studies. Liva’s innovative digital-first coaching platform integrates seamlessly into healthcare systems offering personalised clinical support to more than 50,000 patients. Founded in Denmark, we have expanded our reach across multiple geographies, marking our presence as a global force for advancing better health outcomes. Our collaborations with healthcare systems, including the NHS, as well as partnerships with some of the world’s largest life science companies and health insurers allow us to impact lives on a large scale. Liva is supported by a number of investors across Europe including MIG, Athos, Maj Invest, DHV and Verlinvest.